Published in Int J Gynecol Cancer on February 01, 2010
Is Surgical Menopause Associated With Future Levels of Cardiovascular Risk Factor Independent of Antecedent Levels? The CARDIA Study. Am J Epidemiol (2015) 0.78
The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic review. BMC Womens Health (2017) 0.75
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med (2010) 8.10
Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation (2010) 4.50
Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer (2005) 3.26
Effect of a cholesterol-lowering diet on maternal, cord, and neonatal lipids, and pregnancy outcome: a randomized clinical trial. Am J Obstet Gynecol (2005) 2.01
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation (2007) 2.00
Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial. BMJ (2010) 1.93
Physical activity and the risk of preeclampsia: a systematic review and meta-analysis. Epidemiology (2014) 1.74
Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation. Am J Cardiol (2012) 1.60
Effect of a cholesterol-lowering diet during pregnancy on maternal and fetal Doppler velocimetry: the CARRDIP study. Am J Obstet Gynecol (2007) 1.49
Expression of E-cadherin transcriptional regulators in ovarian carcinoma. Virchows Arch (2006) 1.49
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets. Mol Cancer (2007) 1.44
Trends in the incidence of acute myocardial infarction and stroke: a 21-year follow-up of the Oslo study. Scand Cardiovasc J (2004) 1.42
The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians. Cancer Cell (2011) 1.40
[Good effect of varenicline in snuff use cessation. Double-blind placebo controlled comparative study]. Lakartidningen (2011) 1.39
Reduction in BMI z-score and improvement in cardiometabolic risk factors in obese children and adolescents. The Oslo Adiposity Intervention Study - a hospital/public health nurse combined treatment. BMC Pediatr (2011) 1.37
Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. Eur J Endocrinol (2008) 1.26
Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study. Diabetes Care (2007) 1.24
Bilberry juice modulates plasma concentration of NF-kappaB related inflammatory markers in subjects at increased risk of CVD. Eur J Nutr (2010) 1.24
Leisure time physical activity in middle age predicts the metabolic syndrome in old age: results of a 28-year follow-up of men in the Oslo study. BMC Public Health (2007) 1.20
Determinants of inflammatory markers in a bi-ethnic population. Ethn Dis (2011) 1.17
Physical activity and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis. Eur J Epidemiol (2015) 1.17
Epithelial-mesenchymal transition in ovarian carcinoma. Front Oncol (2012) 1.07
Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis. Gynecol Oncol (2003) 1.06
A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study. Eur Heart J (2005) 1.05
Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2). Gynecol Oncol (2008) 1.05
Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. Clin Cancer Res (2003) 1.05
Preventing obesity: challenges and pitfalls for health promotion. Patient Educ Couns (2009) 1.03
Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms. J Lipid Res (2004) 1.00
INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn's disease? A randomized controlled trial. Inflamm Bowel Dis (2011) 1.00
The gap between guidelines and practice in the treatment of type 2 diabetes A nationwide survey in Norway. Diabetes Res Clin Pract (2008) 0.99
Predictiveness of body mass index for fatal coronary heart disease in men according to length of follow-up: a 21-year prospective cohort study. Scand J Public Health (2007) 0.98
Ovarian cancer: diagnostic, biological and prognostic aspects. Womens Health (Lond Engl) (2014) 0.98
Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin Cancer Res (2006) 0.97
A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection. Ann Surg Oncol (2011) 0.97
Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones? J Clin Oncol (2007) 0.97
Genomic aberration patterns and expression profiles of squamous cell carcinomas of the vulva. Genes Chromosomes Cancer (2013) 0.96
Neoadjuvant chemotherapy is the better treatment option in some patients with stage IIIc to IV ovarian cancer. J Clin Oncol (2011) 0.95
Infant temperament is associated with potentially obesogenic diet at 18 months. Int J Pediatr Obes (2010) 0.95
Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma. Cancer (2008) 0.95
Long-term parental psychological distress among parents of children with a malformation--a prospective longitudinal study. Am J Med Genet A (2010) 0.95
Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia. Atherosclerosis (2006) 0.95
A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer. Gynecol Oncol (2009) 0.93
Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique. Cancer Immunol Immunother (2006) 0.92
Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study. Eur J Cancer (2008) 0.92
[Hormone replacement therapy in menopause and cardiovascular disease--one more time]. Tidsskr Nor Laegeforen (2002) 0.92
Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma. Int J Surg Pathol (2002) 0.92
Health related quality of life after gastric bypass or intensive lifestyle intervention: a controlled clinical study. Health Qual Life Outcomes (2013) 0.92
The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma. Gynecol Oncol (2004) 0.91
Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma. Hum Mutat (2004) 0.91
Image cytometry DNA ploidy correlates with histological subtypes in endometrial carcinomas. Mod Pathol (2006) 0.91
Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev (2014) 0.91
Leg fat mass as measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus men. Scand J Clin Lab Invest (2009) 0.91
Blood cell gene expression associated with cellular stress defense is modulated by antioxidant-rich food in a randomised controlled clinical trial of male smokers. BMC Med (2010) 0.91
Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome. Scand J Clin Lab Invest (2009) 0.90
Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev (2010) 0.90
Ethnic differences in metabolic syndrome among overweight and obese children and adolescents: the Oslo Adiposity Intervention Study. Acta Paediatr (2008) 0.89
Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma. Hum Pathol (2010) 0.88
8-isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases. Cardiovasc Res (2003) 0.88
A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach. Gynecol Oncol (2007) 0.87
Weight cycling and risk of forearm fractures: a 28-year follow-up of men in the Oslo Study. Am J Epidemiol (2008) 0.87
Long-term outcomes after pelvic radiation for early-stage endometrial cancer. J Clin Oncol (2013) 0.87
Validity of the SF-36 in patients with morbid obesity. Obes Facts (2011) 0.87
Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions. Gynecol Oncol (2003) 0.86
Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants with comorbidities and a body mass index ≥27 kg/m(2). Am J Cardiol (2013) 0.86
Accuracy of food intake reporting in obese subjects with metabolic risk factors. Br J Nutr (2006) 0.86
Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters. Am J Clin Pathol (2009) 0.86
HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases. Virchows Arch (2012) 0.86
Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions. Hum Pathol (2011) 0.86
Validation of recall of body weight over a 26-year period in cohort members of the Adventist Health Study 2. Ann Epidemiol (2012) 0.86
Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease. Atherosclerosis (2002) 0.86
Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease. Thromb Res (2002) 0.84
Vitamin C consumption is associated with less progression in carotid intima media thickness in elderly men: A 3-year intervention study. Nutr Metab Cardiovasc Dis (2008) 0.84
Netrin-4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors. Diagn Cytopathol (2010) 0.84
Does excess body fat maintained after the seventh decade decrease life expectancy? J Am Geriatr Soc (2011) 0.84
Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer. Int J Gynecol Cancer (2009) 0.84
MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk. PLoS One (2012) 0.84
Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance. Atherosclerosis (2007) 0.83
Treatment with the PPARgamma agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome. Eur J Endocrinol (2009) 0.83
Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma. Int J Gynecol Pathol (2009) 0.83
Morbidity associated with "self-rated health" in epithelial ovarian cancer survivors. BMC Cancer (2009) 0.83
Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: the Oslo Study cohort. Eur J Prev Cardiol (2011) 0.83
Caveolin-1 expression in ovarian carcinoma is MDR1 independent. Am J Clin Pathol (2002) 0.83
Parenting stress and emotional wellbeing in mothers and fathers of preschool children. Scand J Public Health (2012) 0.83
Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions. Clin Exp Metastasis (2002) 0.82
Impacting obesity and glycemic control using a culturally-sensitive diabetes education program in Hispanic patients with type 2 diabetes. Int J Body Compos Res (2010) 0.82
Validation of ActiReg to measure physical activity and energy expenditure against doubly labelled water in obese persons. Br J Nutr (2008) 0.82
Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe). BMC Med Genet (2010) 0.82
Effect of consumption of dried California mission figs on lipid concentrations. Ann Nutr Metab (2011) 0.82
Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment. Addiction (2009) 0.82
Genomic profile of ovarian carcinomas. BMC Cancer (2014) 0.81
The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma. Gynecol Oncol (2005) 0.81
Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers. Br J Nutr (2011) 0.80
Gross genomic alterations and gene expression profiles of high- grade serous carcinoma of the ovary with and without BRCA1 inactivation. BMC Cancer (2010) 0.80
Intake of Mediterranean foods associated with positive affect and low negative affect. J Psychosom Res (2012) 0.80
Selective mutism: follow-up study 1 year after end of treatment. Eur Child Adolesc Psychiatry (2014) 0.79
Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance. Hum Pathol (2012) 0.79